Promising new malaria vaccine trial begins in burkina faso
NCT ID NCT06958198
First seen Nov 18, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tests a new malaria vaccine designed to target the parasite at multiple stages of its life cycle. It involves 56 healthy adults (18-35 years) and children (5-17 months) in Burkina Faso. The main goal is to check the vaccine's safety and how well it triggers an immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Recherche en Sciences de la Santé
RECRUITINGSiglé, Boulkiemdé Province, BP 7192 OUAGADOUGOU 03, BF, Burkina Faso
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.